Cardiovascular Division


Providing outstanding, innovative clinical care to every patient is our guiding principle. It is the foundation for everything we do and the driving force behind our Lillehei Heart Institute/University of Minnesota Physicians Cardiovascular Program. We are pleased to share with you the scope of our program for service to you, your patients, family members, and friends.

  • February is National Heart Month!

    The Cardiovascular Division and the Lillehei Heart Institute have events planned throughout the month.

  • Dr. Gary Francis co-authors 2 AHA Scientific Statements
    “Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure.” Read Article

    “Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies”  Read Article

  • Chandreshekar appointed
    Editor-in-Chief of JACC Imaging

    Dr. Y.S. Chandreshekar has been appointed Editor-in-Chief of JACC: Cardiovascular Imaging. His term is expected to commence on March 1st, 2017.

  • 2 New Articles from Thenappan Thenappan, M.D.
    “Trends and Outcomes of Pulmonary Arterial Hypertension–Related Hospitalizations in the United States Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012” in JAMA Cardiology. Read Article

    “Pulmonary pulse wave transit time is associated with right ventricular–pulmonary artery coupling in pulmonary arterial hypertension” in Pulmonary Circulation. Read Article

  • New Article in Am J Cardiol by UofM EP Faculty.
    “Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators.”

    The article examines predictors of CV outcomes in implantable cardioverter-defibrillator ICD recipients for primary (G1) versus secondary prevention (G2). Read Article